Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (253)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Molecule	Drug Class / Mechanism	Oncology Type
Everolimus	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Everolimus Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Famitinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Famitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Fedratinib	JAK Inhibitor	Hematologic (MPN)
Molecule Fedratinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (MPN) Drug Class / Mechanism JAK Inhibitor
Fexagratinib	FGFR Inhibitor	Solid Tumour
Molecule Fexagratinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Flumatinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Flumatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Fluzoparib	PARP Inhibitor	Solid Tumour
Molecule Fluzoparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Foretinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Foretinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Fostamatinib	SYK / Multi-Kinase Inhibitor	Hematologic
Molecule Fostamatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Fruquintinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Fruquintinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Furmonertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Furmonertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Futibatinib	FGFR Inhibitor	Solid Tumour
Molecule Futibatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Gandotinib	JAK Inhibitor	Hematologic (MPN)
Molecule Gandotinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (MPN) Drug Class / Mechanism JAK Inhibitor

Everolimus Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Famitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Fedratinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (MPN) Drug Class / Mechanism JAK Inhibitor
Fexagratinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Flumatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Fluzoparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Foretinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Fostamatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Fruquintinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Furmonertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Futibatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Gandotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (MPN) Drug Class / Mechanism JAK Inhibitor

‹ 1 … 6 7 8 9 10 … 22 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (253)

Everolimus

Famitinib

Fedratinib

Fexagratinib

Flumatinib

Fluzoparib

Foretinib

Fostamatinib

Fruquintinib

Furmonertinib

Futibatinib

Gandotinib

Everolimus

Famitinib

Fedratinib

Fexagratinib

Flumatinib

Fluzoparib

Foretinib

Fostamatinib

Fruquintinib

Furmonertinib

Futibatinib

Gandotinib